CD34+ immunoselection of autologous grafts for the treatment of high-risk neuroblastoma.
Marabelle A, Merlin E, Halle P, Paillard C, Berger M, Tchirkov A, Rousseau R, Leverger G, Piguet C, Stephan JL, Demeocq F, Kanold J.
Marabelle A, et al. Among authors: demeocq f.
Pediatr Blood Cancer. 2011 Jan;56(1):134-42. doi: 10.1002/pbc.22840.
Pediatr Blood Cancer. 2011.
PMID: 21058288
Clinical Trial.